A Phase II Trial of the Oral FGF Receptor Inhibitor AZD4547 as 2nd or 3rd Line Therapy in Malignant Pleural Mesothelioma - Trial in Progress

Wei-Sen Lam, Y. C. Gary Lee, Jenette Creaney, Sanjeevan Muruganandan, Michael Millward, Catherine Read, Anna Nowak

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Pages (from-to)S1087-S1087
Number of pages1
JournalJournal of Thoracic Oncology
Volume12
Issue number1
Publication statusPublished - Jan 2017

Cite this